{"schema_version":"secwatch.filing_event.v1","accession":"0000105770-24-000035","form_type":"8-K","ticker":"WST","cik":"0000105770","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2024-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.080203+00:00","generated_at":"2026-06-03T06:11:11.732088+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"West CFO Bernard Birkett transitions to sole CFO; operating duties decentralized","bullets":["CFO Bernard Birkett's role narrowed from CFO & COO to solely CFO effective May 1, 2024; operating leadership moves to business segments.","Shareholders elected 11 directors, approved say-on-pay (96.1% for), and ratified PricewaterhouseCoopers as auditor.","Charter amendments eliminating supermajority requirements for transactions and amendments approved with over 99% support.","A shareholder proposal on redundant topics was not presented after SEC no-action letter in West's favor."],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-24-000035","json":"https://secwatch.observer/filing/0000105770-24-000035.json","markdown":"https://secwatch.observer/filing/0000105770-24-000035.md","text":"https://secwatch.observer/filing/0000105770-24-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577024000035/0000105770-24-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577024000035/wst-20240423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:11:11.732088+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"72efcae078","claim":"Bernard Birkett changed role as Chief Financial Officer at WEST PHARMACEUTICAL SERVICES INC.","evidence_excerpt":"Effective May 1, 2024, Mr. Birkett’s title will be solely Chief Financial Officer (“CFO”), where he will retain financial oversight for both Business Segments, operational oversight of our strategic sourcing function and be involved in key operational issues together with other members of our executive team.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/105770/000010577024000035/0000105770-24-000035-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"role change"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}